text.skipToContent text.skipToNavigation
Pharma & Biotech

Mouse CD1 Brain Striatum Neurons

Catalog #: M-CP-402
Cryopreserved ampule of Mouse CD1 Striatum Neurons containing ≥ 4 million cells
Compare
EA

Product Overview

Ready-to-use CloneticsTM Mouse Brain Striatum Neurons are isolated from Mouse CD1 brain (E14,15).  The cell suspensions of high quality primary embryonic brain neuronal cells (including glia) are prepared by standardized methods, and are ready for immediate culture.

Each vial of striatum cells contains approximately 4 million viable cells. This will seed into 6 or more wells of a 24-well plate and 30 or more wells of a 96-well plate using the recommended plating densities and medium. After approximately 4 days in culture, the cells will form a neurite network and by the 7th day, debris will be minimal.

Recommended Media: PNGMTM BulletKitTM (CC-4461)

Benefits

  • Ready-To-Use 
  • No tissue dissection or animal handling required 
  • Increased data reproducibility
  • Characteristic morphology and staining tests confirm tissue origin and cell type
  • Negative for mycoplasma, bacteria, yeast and fungi
  • Certificate of Analysis (CoA) is available for every batch 

Applications

  • Neurogenesis
  • Neurotransmitter Function
  • Gene Expression
  • Signaling Pathways
  • Electrophysiology
  • Neurotoxicity
  • Drug/Compound Screening
  • Advanced Cell Culture Models

Content & Storage

Content

≥ 4,000,000 cryopreserved cells per ampule

Instructions

Safety Data Sheets (SDS)

Certificate of Analysis (CoA)

Subscribe to our eNewsletter

Keep up to speed on the latest scientific developments, events, tips and tools from Lonza.

Interested in our Webinars?

Need a break from your daily routine? Grab a coffee and check out our free webinars. 

Need a Quote or Any Support?

Are Lonza's primary cells and media applicable to your project? Do you need a quote or any help? Contact us and a local representative will get back to you.

We use cookies to deliver the best service to you. By continuing to browse the site, you are agreeing to our use of cookies.Ok